AUD 0.01
(-16.67%)
Year | Inventory | Inventory Growth |
---|---|---|
2024 | -1.67 Million AUD | 21.65% |
2023 | -2.49 Million AUD | -249023300.0% |
2022 | 1.00 AUD | 100.0% |
2021 | -2.97 Million AUD | 10.08% |
2020 | -3.31 Million AUD | 7.45% |
2019 | -3.57 Million AUD | -71.94% |
2018 | -2.08 Million AUD | -13.11% |
2017 | -1.83 Million AUD | -1265.47% |
2016 | -134.71 Thousand AUD | 0.0% |
2015 | - AUD | 0.0% |
2014 | - AUD | 0.0% |
2013 | - AUD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 FY | - AUD | 100.0% |
2024 Q2 | 1.00 AUD | 0.0% |
2024 Q4 | -1.67 Million AUD | 0.0% |
2023 Q2 | - AUD | 0.0% |
2023 FY | -2.49 Million AUD | -249023300.0% |
2023 Q4 | -2.49 Million AUD | 0.0% |
2022 Q2 | - AUD | 0.0% |
2022 Q4 | 1.00 AUD | 0.0% |
2022 FY | 1.00 AUD | 100.0% |
2021 Q2 | - AUD | 0.0% |
2021 Q4 | -2.97 Million AUD | 0.0% |
2021 FY | -2.97 Million AUD | 10.08% |
2020 Q2 | - AUD | 0.0% |
2020 FY | -3.31 Million AUD | 7.45% |
2020 Q4 | -3.31 Million AUD | 0.0% |
2019 FY | -3.57 Million AUD | -71.94% |
2019 Q2 | - AUD | 0.0% |
2019 Q4 | -3.57 Million AUD | 0.0% |
2018 Q4 | -2.08 Million AUD | 0.0% |
2018 FY | -2.08 Million AUD | -13.11% |
2018 Q2 | - AUD | 0.0% |
2017 FY | -1.83 Million AUD | -1265.47% |
2017 Q4 | -1.86 Million AUD | 0.0% |
2017 Q2 | - AUD | 0.0% |
2016 Q3 | - AUD | 0.0% |
2016 FY | -134.71 Thousand AUD | 0.0% |
2016 Q1 | - AUD | 0.0% |
2016 Q4 | - AUD | 0.0% |
2015 FY | - AUD | 0.0% |
2014 FY | - AUD | 0.0% |
2013 FY | - AUD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Acrux Limited | 147 Thousand AUD | 1242.532% |
Actinogen Medical Limited | 108.82 Thousand AUD | 1643.267% |
AnteoTech Limited | 221.85 Thousand AUD | 857.029% |
Argenica Therapeutics Limited | - AUD | Infinity% |
Arovella Therapeutics Limited | - AUD | Infinity% |
Anatara Lifesciences Ltd | -671.09 Thousand AUD | -150.267% |
Alterity Therapeutics Limited | 1.00 AUD | 167952300.0% |
Amplia Therapeutics Limited | - AUD | Infinity% |
Avecho Biotechnology Limited | 97.11 Thousand AUD | 1829.38% |
Bio-Gene Technology Limited | - AUD | Infinity% |
Biome Australia Limited | 1.88 Million AUD | 188.931% |
Biotron Limited | - AUD | Infinity% |
Botanix Pharmaceuticals Limited | 1.2 Million AUD | 238.875% |
BTC Health Limited | - AUD | Infinity% |
Chimeric Therapeutics Limited | - AUD | Infinity% |
CSL Limited | 8.93 Billion AUD | 100.019% |
Clarity Pharmaceuticals Ltd | - AUD | Infinity% |
Clinuvel Pharmaceuticals Limited | 10.62 Million AUD | 115.805% |
Cynata Therapeutics Limited | 108.2 Thousand AUD | 1652.181% |
Dimerix Limited | - AUD | Infinity% |
EZZ Life Science Holdings Limited | 1.4 Million AUD | 219.864% |
Hexima Limited | - AUD | Infinity% |
Island Pharmaceuticals Limited | -877.24 Thousand AUD | -91.455% |
Immuron Limited | 1.58 Million AUD | 205.99% |
Immutep Limited | 2.00 AUD | 83976200.0% |
Imugene Limited | - AUD | Infinity% |
Invex Therapeutics Ltd | -94.98 Thousand AUD | -1668.234% |
Memphasys Limited | 164.76 Thousand AUD | 1119.369% |
Nanollose Limited | - AUD | Infinity% |
Neuren Pharmaceuticals Limited | - AUD | Infinity% |
Noxopharm Limited | -2.35 Million AUD | 28.811% |
NeuroScientific Biopharmaceuticals Limited | - AUD | Infinity% |
Nyrada Inc. | - AUD | Infinity% |
Orthocell Limited | 1.17 Million AUD | 242.739% |
PharmAust Limited | - AUD | Infinity% |
Patrys Limited | - AUD | Infinity% |
Paradigm Biopharmaceuticals Limited | - AUD | Infinity% |
Proteomics International Laboratories Limited | - AUD | Infinity% |
Prescient Therapeutics Limited | - AUD | Infinity% |
PYC Therapeutics Limited | -17.99 Million AUD | 90.667% |
Race Oncology Limited | 16.4 Thousand AUD | 10340.363% |
Radiopharm Theranostics Limited | -987.41 Thousand AUD | -70.093% |
Recce Pharmaceuticals Ltd | - AUD | Infinity% |
Starpharma Holdings Limited | 2.4 Million AUD | 169.748% |
Telix Pharmaceuticals Limited | 17.31 Million AUD | 109.703% |
Tissue Repair Ltd | 214.72 Thousand AUD | 882.184% |
Zelira Therapeutics Limited | 1.25 Million AUD | 234.114% |